Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 Variants

BACKGROUND: The emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants BA.1, BA.2, and BA.4/5 demonstrate higher transmission and infection rates than previous variants of concern. To evaluate effectiveness of heterologous and homologous booster vaccination, we directl...

Descripción completa

Detalles Bibliográficos
Autores principales: Jäger, Michael, Diem, Gabriel, Sahanic, Sabina, Fux, Vilmos, Griesmacher, Andrea, Lass-Flörl, Cornelia, Wilflingseder, Doris, Tancevski, Ivan, Posch, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345468/
https://www.ncbi.nlm.nih.gov/pubmed/36869832
http://dx.doi.org/10.1093/infdis/jiad057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345468/
https://www.ncbi.nlm.nih.gov/pubmed/36869832
http://dx.doi.org/10.1093/infdis/jiad057

Ejemplares similares